Nasdaq:US$18.16 (-0.83) | HKEX:HK$30.35 (+0.00) | AIM:£2.90 (-0.14)
新闻中心及演示文稿
上一篇文章   |   下一篇文章
演示文稿, 科学出版物 | 2012-10-14

ISSX 2012: Pharmacokinetic/Pharmacodynamic Modeling of Epitinib to Evaluate the Anti-cancer Effect on A431 Tumor Xenograft in Nude Mice